Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components

Journal of Clinical Investigation

Volumn 99, Issue 6, 1997, Pages 1187-1199

  Ader, Marilyn ^a   Ni, Ta Chen ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

dose response; glucose effectiveness; glucose turnover; intravenous glucose tolerance test; mathematical modeling

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DOG; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030901308     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119275     Document Type: Article

References (53)

1. Fuller, J.H., M.J. Shipley, G. Rose, R.J. Jarrett, and H. Keen. 1980. Coronary heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet. i:1373-1376.
2. Bergman, R.N., Y.Z. Ider, C.R. Bowden, and C. Cobelli. 1979. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236:E667-E677.
3. Ader, M., G. Pacini, Y.J. Yang, and R.N. Bergman. 1985. Importance of glucose per se to intravenous glucose tolerance: comparison of the minimal model prediction with direct measurements. Diabetes. 34:1092-1103.
4. Bergman, R.N., T.-C. Ni, and M. Ader. 1996. Glucose effectiveness. In Clinical Research in Diabetes. B. Draznin and R. A. Rizza, editors. Humana Press, Totowa, NJ. pp. 81-100.
5. Martin, B.C., J.H. Warram, A.S. Krolewski, R.N. Bergman, J.S. Soeldner, and C.R. Kahn. 1992. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 340:925-929.
6. Quon, M.J., C. Cochran, S.I. Taylor, and R.C. Eastman. 1994. Non-insulin-mediated glucose disappearance in subjects with IDDM: discordance between experimental results and minimal model analysis. Diabetes. 43:890-896.
7. Finegood, D.T., and D. Tzur. 1996. Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am. J. Physiol. 271:E485-495.
8. Vicini, P., A. Avogaro, A. Valerio, A. Caumo, and C. Cobelli. 1996. Glucose effectiveness, clearance rate and peripheral insulin sensitivity are impaired in NIDDM subjects: a hot IVGTT minimal model study. Diabetes. 45 (Suppl. 2):100a. (Abstr.)
9. Christopher, M.J., C. Rantzau, G.M. Ward, and F.P. Alford. 1995. Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI. Am. J. Physiol. 268:E410-E421.
10. Cobelli, C., G. Pacini, G. Toffolo, and L. Sacca. 1986. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am. J. Physiol. 250:E591-E598.
11. Ader, M., and R.N. Bergman. 1990. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am. J. Physiol. 258: E1020-E1032.
12. Andersen, L., B. Dinesen, P.N. Jorgensen, F. Poulsen, and M.E. Roder. 1993. Enzyme immunoassay for intact human insulin in serum or plasma. Clin. Chem. 39:578-582.
13. Somogyi, M. 1945. Determination of blood sugar. J. Biol. Chem. 160:69-73.
14. Jacquez, J.A. 1992. Theory of production rate calculations in steady and non-steady states and its application to glucose metabolism. Am. J. Physiol. 262:E779-E790. (Editorial).
15. Cobelli, C., G. Toffolo, and E. Ferrannini. 1984. A model of glucose kinetics and their control by insulin: compartmental and noncompartmental approaches. Mathematical Biosciences. 72:291-315.
16. Norwich, K.H. 1977. Molecular Dynamics in Biosystems: The Kinetics of Tracers in Intact Organisms. Pergamon Press, Oxford. 405 pp.
17. Radziuk, J., K.H. Norwich, and M. Vranic. 1978. Experimental validation of measurements of glucose turnover in non-steady state. Am. J. Physiol. 234:E84-E93.
18. 14C-labeled glucose. Biochem. J. 142:171-183.
19. Bergman, R.N., D.T. Finegood, and M. Ader. 1985. Assessment of insulin sensitivity in vivo. Endocr. Rev. 6:45-86.
20. Hendrick, G.K., R.T. Frizzell, and A.D. Cherrington. 1987. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting. Am. J. Physiol. 253:E443-E452.
21. Best, J.D., G.J. Taborsky, Jr., J.B. Halter, and D. Porte, Jr. 1981. Glucose disposal is not proportional to plasma glucose level in man. Diabetes. 30: 847-850.
22. Verdonk, C.A., R.A. Rizza, and J.E. Gerich. 1981. Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes. 30:535-537.
23. Bergman, R.N. 1989. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes. 38:1512-1527. (Lilly Lecture.)
24. Welch, S., S.S.P. Gebhart, R.N. Bergman, and L.S. Phillips. 1990. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 71:1508-1518.
25. Henriksen, J.E., F. Alford, A. Handberg, A. Vaag, G.M. Ward, A. Kalfas, and H. Beck-Nielsen. 1994. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94:1196-1204.
26. Porte, D., Jr. 1991. B-cells in type II diabetes mellitus. Diabetes. 40:166-180. (Banting Lecture.)
27. Alzaid, A.A., S.F. Dinneen, D.J. Turk, A. Caumo, C. Cobelli, and R.A. Rizza. 1994. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J. Clin. Invest. 94:2341-2348.
28. Bonadonna, R.C., S. Del Prato, M.P. Saccomani, E. Bonora, G. Gulli, E. Ferrannini, D. Bier, C. Cobelli, and R.A. DeFronzo. 1993. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J. Clin. Invest. 92:486-494.
29. Ader, M., and T.-C. Ni. 1996. Glucose effectiveness accounts for 42% of glucose disposal after oral glucose. Diabetes. 45 (Suppl. 2):100a. (Abstr.)
30. Gottesman, I., L. Mandarino, and J. Gerich. 1983. Estimation and kinetic analysis of insulin-independent glucose uptake in human subjects. Am. J. Physiol. 224:E632-E635.
31. Vranic, M. P. Fono, N. Kovacevic, and B. J. Lin. 1971. Glucose kinetics and fatty acids in dogs on matched insulin infusion after glucose load. Metab. Clin. Exp. 20:954-967.
32. Lund-Andersen, H. 1979. Transport of glucose from blood to brain. Physiol. Rev. 59:305-352.
33. Rebrin, K., G.M. Steil, L. Getty, and R.N. Bergman. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
34. Bradley, D.C., R.A. Poulin, and R.N. Bergman. 1992. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes. 42:296-306.
35. Farrace, S., and L. Rossetti. 1992. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats. Diabetes. 41:1453-1463.
36. Kruszynska, Y.T., P.D. Home, and K.G.M.M. Alberti. 1986. In vivo regulation of liver and skeletal muscle glycogen synthase activity by glucose and insulin. Diabetes. 35:662-667.
37. 12 myotubes and rat skeletal muscle. Diabetes. 44:646-651.
38. Kahn, S.E., R.L. Prigeon, D.K. McCulloch, E.J. Boyko, R.N. Bergman, M.W. Schwartz, J.L. Neifing, W.K. Ward, J.C. Beard, J.P. Palmer, and D. Porte, Jr. 1994. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes. 43:587-592.
39. Steil, G.M., J. Murray, R.N. Bergman, and T.A. Buchanan. 1994. Repeatability of insulin sensitivity and glucose effectiveness from the minimal model: implications for study design. Diabetes. 43:1365-1371.
40. Hobbs, C.J., R.E. Jones, and S.R. Plymate. 1996. Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. J. Clin. Endocrinol. Metab. 81:1582-1585.
41. Baron, A.D., G. Brechtel, P. Wallace, and S.V. Edelman. 1988. Rates and tissue sites of non-insulin-and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255:E769-E774.
42. Edelman, S.V., M. Laakso, P. Wallace, G. Brechtel, J.M. Olefsky, and A.D. Baron. 1990. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes. 39:955-964.
43. Baron, A.D., O.G. Kolterman, J. Bell, L.J. Mandarino, and J.M. Olefsky. 1985. Rates of non-insulin-mediated glucose uptake are elevated in type II diabetic subjects. J. Clin. Invest. 76:1782-1788.
44. Raman, M., J. Radziuk, and G.J. Hetenyi. 1990. Distribution and kinetics of glucose in rat analyzed by noncompartmental and compartmental analysis. Am. J. Physiol. 259:E292-E303.
45. Insel, P.A., J.E. Liljenquist, J.D. Tobin, R.S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55:1057-1066.
46. Atkins, G. 1980. A new technique for maintaining and monitoring conscious, stress-free rabbits in a steady state: its use in the determination of glucose kinetics. Quart. J. Exp. Physiol. 65:63-75.
47. Caumo, A., and C. Cobelli. 1993. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am. J. Physiol. 264:E829-E841.
48. Osei, K., and D.P. Schuster. 1995. Metabolic characteristics of African descendants: a comparative study of African-Americans and Ghanaian immigrants using minimal model analysis. Diabetologia. 38:1103-1109.
49. Yang, Y.J., J.H. Youn, and R.N. Bergman. 1987. Modified protocols improve insulin sensitivity estimation using the minimal model. Am. J. Physiol. 253:E595-E602.
50. Avogaro, A., J.D. Bristow, D.M. Bier, C. Cobelli, and G. Toffolo. 1989. Stable-label intravenous glucose tolerance test minimal model. Diabetes. 38: 1048-1055.
51. Caumo, A., A. Giacca, M. Morgese, G. Pozza, P. Micossi, and C. Cobelli. 1991. Minimal models of glucose disappearance: lessons from the labeled IVGTT. Diab. Med. 8:822-832.
52. Jacquez, J.A. 1985. Compartmental Analysis in Biology and Medicine. University of Michigan Press, Ann Arbor. 560 pp.
53. Watanabe, R.M., J. Lovejoy, G.M. Steil, M. DiGirolamo, and R.N. Bergman. 1995. Insulin sensitivity accounts for glucose and lactate kinetics after intravenous glucose. Diabetes. 44:954-962.